Osteonecrosis is a disabling complication of treatment for pediatric acute lymphoblastic leukemia, and much effort has been made to predict which patients are prone to develop this disease. Multiple clinical and genetic factors have already been identified as being associated with osteonecrosis; however, a prediction model that combines pretreatment genetic biomarkers and clinical factors has not yet been designed. Such a prediction model can only be developed with continuing international collaborations and research efforts, including large genome-wide association studies.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s40291-016-0226-z | DOI Listing |
Publication Analysis
Top Keywords
genetic biomarkers
8
acute lymphoblastic
8
lymphoblastic leukemia
8
prediction model
8
biomarkers identify
4
identify risk
4
risk osteonecrosis
4
osteonecrosis children
4
children acute
4
leukemia osteonecrosis
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!